S&P 500 concentration risk is surging—top 10 now 41%. See a quant-optimized 15-stock barbell from Strong Buy picks for better ...
Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...
Tempus AI, Inc. TEM recently announced a collaboration with Median Technologies to integrate Median’s proprietary eyonis LCS solution into the Tempus Pixel platform. The integration is expected to ...
Fewer interval cancers that were invasive, T2+, or non-luminal A were found in group with AI-supported mammography versus standard double reading. HealthDay News — Artificial intelligence ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a collaboration with Median Technologies (EPA: ...
DENVER (KDVR) — The death of actor James Van Der Beek, best known for his role in Dawson’s Creek, is renewing national attention on colorectal cancer and the importance of early screening. Doctors say ...
AMC has opted out of screening the award-winning short film during its third-party programmed pre-show, and it’s unclear if other chains will follow suit. By James Hibberd Writer-at-Large It was ...
AMC Theatres has opted out of screening the AI-generated short “Thanksgiving Day,” which won a film festival contest whose prize included showcasing the winner at cinemas across the U.S. Earlier this ...
The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered software program to assist with lung cancer screening. The software was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results